Anupam Rasayan India Ltd

ANURASSpecialty Chemicals
1245.30+0.00 (+0.00%)
As on 30 Jan 2026, 01:37 pmMarket Closed

Fundamental Score

...

Anupam Rasayan India Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

3.32%
Poor

Return on Capital Employed

7.33%
Excellent

Operating Profit Margin (5Y)

26.75%
Poor

Dividend Yield

0.06%

Valuation Metrics

Poor

Price to Earnings

92.84x

Market Capitalization

14.04K (Cr)

Industry P/E

29.20x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

166.29%
Excellent

YoY Quarterly Sales Growth

148.81%
Excellent

Sales Growth (5Y)

22.13%
Poor

EPS Growth (5Y)

-4.35%
Good

Profit Growth (5Y)

11.97%

Financial Health

Good

Debt to Equity

0.38x
Good

Interest Coverage

3.12x
Poor

Free Cash Flow (5Y)

-1.31K (Cr)

Ownership Structure

Good

Promoter Holding

59.07%
Average

FII Holding

7.63%
Poor

DII Holding

1.37%
Average

Pledged Percentage

17.51%
Market-cap Classification
Mid-cap
Balance of growth potential and stability.
59.07%
Promoter Holding
14.04K (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of ANURAS across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Strong Operating Margins (26.75%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Robust Profit Growth (166.29%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (148.81%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Consistent Growth Track Record (22.13% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Balanced Promoter Holding (59.07%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Risk Factors

9 factors identified

Below-Average Return on Equity (3.32%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (7.33%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.

Premium Valuation Risk (P/E: 92.84x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

Weak Earnings Growth (-4.35% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.

Negative Free Cash Flow (₹-1314.41 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Limited Institutional Interest (FII+DII: 9.00%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

Very Low ROE

Observation: Poor capital utilization and shareholder returns.

Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Very High P/E Ratio

Observation: Significant overvaluation risk present.

Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.

Financial Statements

Comprehensive financial data for Anupam Rasayan India Ltd

About ANURAS

Business Overview

Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.

Company Details

Symbol:ANURAS
Industry:Specialty Chemicals
Sector:Specialty Chemicals

Key Leadership

Mr. Gopal Puranmal Agrawal
Chief Executive Officer
Ms. Mona Anandbhai Desai
Vice Chairman & Whole-Time Director
Mr. Amit Ajitbhai Khurana
Chief Financial Officer

Corporate Events

Recent
Ex-Dividend Date
2025-07-21

ANURAS Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)3.32%
Return on Capital Employed7.33%
Operating Profit Margin (5Y)26.75%
Debt to Equity Ratio0.38
Interest Coverage Ratio3.12

Growth & Valuation

Sales Growth (5Y)22.13%
Profit Growth (5Y)11.97%
EPS Growth (5Y)-4.35%
YoY Quarterly Profit Growth166.29%
YoY Quarterly Sales Growth148.81%

Frequently Asked Questions

What is the current price of Anupam Rasayan India Ltd (ANURAS)?

As of 30 Jan 2026, 01:37 pm IST, Anupam Rasayan India Ltd (ANURAS) is currently trading at ₹1245.30. The stock has a market capitalization of ₹14.04K (Cr).

Is ANURAS share price Overvalued or Undervalued?

ANURAS is currently trading at a P/E ratio of 92.84x, compared to the industry average of 29.20x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.

What factors affect the Anupam Rasayan India Ltd share price?

Key factors influencing ANURAS's price include its quarterly earnings growth (Sales Growth: 148.81%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Anupam Rasayan India Ltd a good stock for long-term investment?

Anupam Rasayan India Ltd shows a 5-year Profit Growth of 11.97% and an ROE of 3.32%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.38 before investing.

How does Anupam Rasayan India Ltd compare with its industry peers?

Anupam Rasayan India Ltd competes with major peers in the Specialty Chemicals. Investors should compare ANURAS's P/E of 92.84x and ROE of 3.32% against the industry averages to determine its competitive standing.

What is the P/E ratio of ANURAS and what does it mean?

ANURAS has a P/E ratio of 92.84x compared to the industry average of 29.20x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹93 for every ₹1 of annual earnings.

How is ANURAS performing according to Bull Run's analysis?

ANURAS has a Bull Run fundamental score of 37.5/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does ANURAS belong to?

ANURAS operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Anupam Rasayan India Ltd.

What is Return on Equity (ROE) and why is it important for ANURAS?

ANURAS has an ROE of 3.32%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Anupam Rasayan India Ltd generates profits from shareholders' equity.

How is ANURAS's debt-to-equity ratio and what does it indicate?

ANURAS has a debt-to-equity ratio of 0.38, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.

What is ANURAS's dividend yield and is it a good dividend stock?

ANURAS offers a dividend yield of 0.06%, which means you receive ₹0.06 annual dividend for every ₹100 invested.

How has ANURAS grown over the past 5 years?

ANURAS has achieved 5-year growth rates of: Sales Growth 22.13%, Profit Growth 11.97%, and EPS Growth -4.35%.

What is the promoter holding in ANURAS and why does it matter?

Promoters hold 59.07% of ANURAS shares, with 17.51% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is ANURAS's market capitalization category?

ANURAS has a market capitalization of ₹14037 crores, placing it in the Mid-cap category.

How volatile is ANURAS stock?

ANURAS has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for ANURAS?

ANURAS has a 52-week high of ₹N/A and low of ₹N/A.

What is ANURAS's operating profit margin trend?

ANURAS has a 5-year average Operating Profit Margin (OPM) of 26.75%, indicating the company's operational efficiency.

How is ANURAS's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 148.81% and YoY Profit Growth of 166.29%.

What is the institutional holding pattern in ANURAS?

ANURAS has FII holding of 7.63% and DII holding of 1.37%. Significant institutional holding often suggests professional confidence in the stock.